Bank of New York Mellon’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $377K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $131K | Sell |
|
|||||
|
2023
Q4 | $119K | Sell |
|
|||||
|
2023
Q3 | $278K | Sell |
|
|||||
|
2023
Q2 | $535K | Sell |
|
|||||
|
2023
Q1 | $1.99M | Buy |
|
|||||
|
2022
Q4 | $4.35M | Sell |
|
|||||
|
2022
Q3 | $4.04M | Buy |
|
|||||
|
2022
Q2 | $3.63M | Sell |
|
|||||
|
2022
Q1 | $5.34M | Buy |
|
|||||
|
2021
Q4 | $5.31M | Buy |
|
|||||
|
2021
Q3 | $6.4M | Buy |
|
|||||
|
2021
Q2 | $5.81M | Buy |
|
|||||
|
2021
Q1 | $3.68M | Sell |
|
|||||
|
2020
Q4 | $2.7M | Sell |
|
|||||
|
2020
Q3 | $2.3M | Sell |
|
|||||
|
2020
Q2 | $3.14M | Buy |
|
|||||
|
2020
Q1 | $2.36M | Buy |
|
|||||
|
2019
Q4 | $2.86M | Sell |
|
|||||
|
2019
Q3 | $3.62M | Buy |
|
|||||
|
2019
Q2 | $3.05M | Sell |
|
|||||
|
2019
Q1 | $2.82M | Sell |
|
|||||
|
2018
Q4 | $1.89M | Buy |
|
|||||
|
2018
Q3 | $3.41M | Buy |
|
|||||
|
2018
Q2 | $2.46M | Sell |
|
|||||
|
2018
Q1 | $1.59M | Buy |
|
|||||
|
2017
Q4 | $1.52M | Buy |
|
|||||
|
2017
Q3 | $1.66M | Sell |
|
|||||
|
2017
Q2 | $2.73M | Buy |
|
|||||
|
2017
Q1 | $2.59M | Sell |
|
|||||
|
2016
Q4 | $1.36M | Buy |
|
|||||
|
2016
Q3 | $658K | Sell |
|
|||||
|
2016
Q2 | $429K | Sell |
|
|||||
|
2016
Q1 | $640K | Buy |
|
|||||
|
2015
Q4 | $1.65M | Buy |
|
|||||
|
2015
Q3 | $938K | Buy |
|
|||||
|
2015
Q2 | $734K | Buy |
|
|||||
|
2015
Q1 | $239K | Buy |
|
|||||
|
2014
Q4 | $234K | Sell |
|
|||||
|
2014
Q3 | $252K | Buy |
|
|||||
|
2014
Q2 | $404K | Buy |
|
|||||
|
2014
Q1 | $245K | Buy |
|